Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip to main content
Donate

Let's beat cancer sooner

Blank Avatar

Henry spent four years at university studying biochemistry before realising that the laboratory life wasn’t for him, and going to work for a science journal instead. From there, he went on to do a Masters in Science Communication and, after a brief flirtation with science journalism, in 2003 he started working for Cancer Research UK. He manages the charity’s news feed and this blog.

The route to ‘precision’ medicine – four key challenges we need to meet

Category: Science blog January 13, 2016

We look at the key themes that emerged from the first ever Molecular Analysis for Personalised Therapy conference in Paris last year

Read More

Grand Challenge three: prevent cancer by studying ‘scars’ in its DNA

Category: Science blog January 5, 2016

This entry is part 4 of 8 in the series Grand Challenge

The third of our Grand Challenge topics asks: can we prevent cancer by studying ‘scars’ in its DNA?

Read More

BBC Panorama’s tobacco industry revelations are genuinely shocking

Category: Science blog December 1, 2015

Last night’s Panorama on BBC1 contained new – and shocking – allegations about the behaviour of one of the world’s biggest tobacco companies

Read More

Diesel emissions – an emerging public health issue?

Category: Science blog November 24, 2015

As experts call for more research into the influence of diesel emissions on lung cancer rates in non-smokers, we take a look at the state of the evidence.

Read More

NCRI cancer conference day 3: radiotherapy, lifestyle… and a pill to prevent cancer?

Category: Science blog November 4, 2015

All the events from the third day of this year’s National Cancer Research Institute conference in Liverpool

Read More

Our milestones: the birth of a new prostate cancer drug

Category: Science blog September 21, 2015

This entry is part 24 of 25 in the series Our milestones

We look back to the 1990s, and to our ‘first-in-man’ trial of prostate cancer drug abiraterone – a vital step in the drug’s development

Read More

Expert Opinion – Professor Peter Johnson on cancer immunotherapy

Category: Science blog September 17, 2015

We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.

Read More